Science & Research
Alpha Tau FDA Clearance Expands REGAIN Glioblastoma Trial Enrollment
Early interim data signal a potential breakthrough in locoregional tumor control, though the therapy sits outside conve…
Science & Research 42 stories
Science & Research
Liquidia to Present ASCENT Cough Data at PHA 2026 Conference
The Dallas conference brings together pulmonary hypertension researchers and clinicians as inhaled-therapy delivery for…
Science & Research
RenovoRx TAMP™ Gemcitabine Data Published in Peer-Reviewed Journal
PET-CT imaging outperformed CT alone in detecting therapeutic response, potentially reshaping monitoring protocols for …
Science & Research
Caribou Biosciences Vispa-cel Posts 82% ORR in Lymphoma Trial
Single-dose outpatient tolerability profile positions the therapy for community oncology center expansion as allogeneic…
Science & Research
Oryzon's LSD1 Inhibitor Posts Updated AML Data at EHA 2026
Epigenetic enzyme inhibition enters a new data cycle as Oryzon's iadademstat shows continued signal in acute myeloid le…
Science & Research
Rein Therapeutics Expands Phase 2 IPF Trial to United Kingdom
The NASDAQ-listed clinical-stage biopharma is broadening its orphan pulmonary fibrosis program beyond the U.S. as IPF p…
Science & Research
Cartigenix HP® RCT Reports 64% WOMAC Pain Reduction in 90 Days
Cartilage regeneration biomarkers add mechanistic weight to the joint-health claim, positioning the ingredient for stru…
Science & Research
CLK Inhibitor BH-30236 Shows Early Anti-Leukemic Activity in Phase 1 Trial
Initial data presented at EHA 2026 suggest tolerability in relapsed/refractory AML and HR-MDS patients, including those…
Science & Research
Scenic Biotech Enters MJFF LITE Program for Parkinson's Research
The partnership signals growing biotech interest in modifier-gene pathways, with potential downstream implications for …
Science & Research
Needle-Free Epinephrine Spray Targets Anaphylaxis Treatment Gap
ALK's EAACI data highlight adherence and administration barriers that a needle-free delivery format could address for a…
Science & Research
Humacyte ATEV Hits Phase 3 Superiority Mark in Dialysis Access Trial
A supplemental BLA filing is planned for H2 2026, potentially expanding clinical options in vascular access — a space a…
Science & Research
Urteste Enrolls First Patient in Panuri Pancreatic Cancer Diagnostic Study
The milestone marks a formal clinical entry point for a diagnostic approach that could reshape early-detection protocol…